(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Multiple Sclerosis
If you are aged 18 to 55, have multiple sclerosis with at least one relapse during the past year, are able to walk without aid or rest more than 100 meters, and have failed treatment with a beta-interferon, you may qualify for this study.
The research site is in Lenexa, Kansas.
More information
Please see http://www.centerwatch.com/patient/studies/cat102.html.
-----
Moyamoya Syndrome
If you are 18 or older and capable of informed consent, you may qualify for this study. Both asymptomatic and symptomatic patients with moyamoya will be included.
The research site is in St. Louis, Mo.
More information
Please see http://www.centerwatch.com/patient/studies/cat652.html.
-----
Pancreatic Cancer
If you are 18 or older; have unresectable, locally advanced adenocarcinoma of the pancreas proven by biopsy or cytology; have not been treated for pancreatic cancer; and have a life expectancy greater than three months, you may qualify for this study.
The research site is in Greenville, N.C.
More information
Please see http://www.centerwatch.com/patient/studies/cat35.html.
-----
Copyright 2008 Thomson CenterWatch. All rights reserved.
2008
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.
